Moschen Alexander R, Tilg Herbert
Department of Medicine, Christian Doppler Research Laboratory for Gut Inflammation, Innsbruck Medical University, Innsbruck, Austria.
Curr Opin Clin Nutr Metab Care. 2008 Sep;11(5):620-5. doi: 10.1097/MCO.0b013e32830b5d09.
Overnutrition resulting in obesity plays a key role in nonalcoholic fatty liver disease, the major reason for abnormal liver function in many parts of the world. Currently, it is not clear which type of diet preferentially results in this common disease.
Excess nutrition leads to accumulation of various lipids in the liver, where fatty acids are considered the main driving force in the disease process. A liver loaded with fat is commonly associated with insulin resistance, the key pathophysiological phenomenon observed in nonalcoholic fatty liver disease. Not surprisingly, attempts to reduce body weight and thereby total liver fat are considered the key therapeutical steps in this disorder. Although voluntary weight loss is often not successful to reverse the disease process, various surgical procedures have proven effective in reducing overweight situations and liver steatosis. Weight loss not only reduces the amount of liver fat but also might improve inflammation and fibrosis in nonalcoholic steatohepatitis.
Although pharmacological approaches are eagerly awaited to achieve similar benefits; current available therapies have so far not fulfilled this expectation. Despite this frustration, such approaches are expected to be available in the near future.
导致肥胖的营养过剩在非酒精性脂肪性肝病中起关键作用,这是世界许多地区肝功能异常的主要原因。目前尚不清楚哪种饮食类型会优先引发这种常见疾病。
营养过剩会导致肝脏中各种脂质蓄积,其中脂肪酸被认为是疾病进程的主要驱动力。脂肪堆积的肝脏通常与胰岛素抵抗相关,这是在非酒精性脂肪性肝病中观察到的关键病理生理现象。不出所料,试图减轻体重从而减少肝脏总脂肪量被认为是治疗这种疾病的关键步骤。尽管自愿减肥往往无法成功逆转疾病进程,但各种外科手术已被证明在减轻超重情况和肝脂肪变性方面有效。体重减轻不仅会减少肝脏脂肪量,还可能改善非酒精性脂肪性肝炎中的炎症和纤维化。
尽管人们急切期待药物治疗能带来类似的益处;但目前可用的疗法尚未达到这一期望。尽管令人沮丧,但预计此类疗法在不久的将来会出现。